Catecholamines suppress fatty acid re-esterification and increase oxidation in white adipocytes via STAT3
- Nat Metab. 2020 Jul;2(7):620-634. doi: 10.1038/s42255-020-0217-6.
- 1. Division of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. [email protected].
- 2. Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA. [email protected].
- 3. Division of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
- 4. Gene Expression Laboratory, Salk Institute for Biological Sciences, La Jolla, CA, USA.
- 5. Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
- 6. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- 7. Department of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
- 8. Cytokinetics, South San Francisco, CA, USA.
- 9. Division of Metabolism and Endocrinology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. [email protected].
- 10. Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA. [email protected].
- 11. Department of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. [email protected].
Catecholamines stimulate the mobilization of stored triglycerides in adipocytes to provide fatty acids (FAs) for Other tissues. However, a large proportion is taken back up and either oxidized or re-esterified. What controls the disposition of these FAs in adipocytes remains unknown. Here, we report that catecholamines redirect FAs for oxidation through the phosphorylation of signal transducer and activator of transcription 3 (STAT3). Adipocyte STAT3 is phosphorylated upon activation of β-adrenergic receptors, and in turn suppresses FA re-esterification to promote FA oxidation. Adipocyte-specific STAT3 KO mice exhibit normal rates of lipolysis, but exhibit defective lipolysis-driven oxidative metabolism, resulting in reduced energy expenditure and increased adiposity when they are on a high-fat diet. This previously unappreciated, non-genomic role of STAT3 explains how sympathetic activation can increase both lipolysis and FA oxidation in adipocytes, revealing a new regulatory axis in metabolism.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: AcyltransferaseResearch Areas: Metabolic Disease